{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Nicolas A"],"pubmed_abstract":["<h4>Background</h4>Interstitial lung disease (ILD) is the leading cause of mortality in systemic sclerosis (SSc).<h4>Objective</h4>We performed an overview of the diagnostic approaches, follow-up and treatment strategies used in France for the management of SSc-associated ILD (SSc-ILD).<h4>Design structured nationwide online surveymethods</h4>A structured nationwide online survey was submitted to participants <i>via</i> the French Medical Societies for Internal Medicine and Pneumology, and research groups on SSc-ILD from May 2018 to June 2020. The 79 multiple-choice and 9 open-ended questions covered the screening of ILD at baseline, monitoring of patients with established SSc-ILD and its management. Fourteen optional vignettes exploring different clinical phenotypes of SSc-ILD were submit"],"journal":["Therapeutic advances in musculoskeletal disease"],"pagination":["1759720X231159712"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10176589"],"repository":["biostudies-literature"],"pubmed_title":["Systemic sclerosis associated interstitial lung disease: a survey of current practices in France."],"pmcid":["PMC10176589"],"pubmed_authors":["Queyrel V","Mouthon L","Mekinian A","Hachulla E","Launay D","Groupe Orphalung, Groupe Francophone de Recherche sur la Sclérodermie","Gachet B","Leroy S","Uzunhan Y","Martis N","Nicolas A","Cottin V"],"additional_accession":[]},"is_claimable":false,"name":"Systemic sclerosis associated interstitial lung disease: a survey of current practices in France.","description":"<h4>Background</h4>Interstitial lung disease (ILD) is the leading cause of mortality in systemic sclerosis (SSc).<h4>Objective</h4>We performed an overview of the diagnostic approaches, follow-up and treatment strategies used in France for the management of SSc-associated ILD (SSc-ILD).<h4>Design structured nationwide online surveymethods</h4>A structured nationwide online survey was submitted to participants <i>via</i> the French Medical Societies for Internal Medicine and Pneumology, and research groups on SSc-ILD from May 2018 to June 2020. The 79 multiple-choice and 9 open-ended questions covered the screening of ILD at baseline, monitoring of patients with established SSc-ILD and its management. Fourteen optional vignettes exploring different clinical phenotypes of SSc-ILD were submit","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2025-04-26T01:44:30.117Z","creation":"2025-04-06T10:11:07.841Z"},"accession":"S-EPMC10176589","cross_references":{"pubmed":["37187855"],"doi":["10.1177/1759720X231159712"]}}